08.07.26 -- Global Ties, Good Fortune Bind Biotech And CDMO

Explore how comprehensive API testing can optimize drug formulation and enhance bioavailability to ensure the success of your pharmaceutical products.

Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.

Reduce formulation and scale-up risk with integrated development and manufacturing expertise for complex OSD products.

Ensure your press is running with optimal efficiency by expanding your knowledge of proper cleaning and maintenance.

As complex therapies continue to evolve, advanced lyophilization approaches can help improve stability, consistency, scalability, and product quality.

Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.

Designing chemicals to degrade safely reduces environmental risk. Balancing business needs with planned degradation, starting in the early design phase, ensures a sustainable lifecycle.

Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.

Finding alternative solvent approaches could allow for lower volumes of less toxic solvents, significantly improving both the environmental and human health implications of new drugs produced.

See how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.